STOCK TITAN

Rxsight, Inc. SEC Filings

RXST NASDAQ

Welcome to our dedicated page for Rxsight SEC filings (Ticker: RXST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

RxSight, Inc. filings document the public-company record for a Nasdaq-listed ophthalmic medical device issuer centered on the RxSight Light Adjustable Lens system. Form 8-K reports furnish operating results, sales guidance, Light Adjustable Lens and Light Delivery Device commercial metrics, preliminary results and other material updates tied to financial condition.

The company’s proxy and governance filings cover annual meeting matters, board and committee composition, executive compensation, equity awards and stockholder voting procedures. Other current reports address officer appointments, transition agreements, compensatory arrangements and the registered common stock structure for RXST.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.7%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.84%
Tags
current report

FAQ

How many Rxsight (RXST) SEC filings are available on StockTitan?

StockTitan tracks 46 SEC filings for Rxsight (RXST), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Rxsight (RXST)?

The most recent SEC filing for Rxsight (RXST) was filed on August 7, 2025.